Cynvenio Biosystems, Inc.

27 articles about Cynvenio Biosystems, Inc.

• Cynvenio Announces ClearID Total Insight, A New Comprehensive Liquidbiopsy Monitoring Program For Breast Cancer

  3/10/2017

• Cynvenio And Color Partner To Offer Comprehensive Hereditary And Somatic Cancer Testing From Simple Blood Draw

  2/23/2017

• Cynvenio, Milenia Labs Release: Companies Enter Into Exclusive Distribution Agreement For ClearID Breast Cancer Testing In Mexico

  1/26/2017

• Cynvenio Releases Second-Generation ClearID Breast Cancer Blood Test

  1/9/2017

• Cynvenio Clinical Trial Data Supports Benefits Of Multi-Template Liquid Biopsy Sequencing For Cancer Mutational Profiling

  4/5/2016

• Cynvenio Honors Triple Negative Breast Cancer Day With Clinical Trial Launch And Event At Pink Lotus Breast Center In Los Angeles

  3/3/2016

• Cynvenio Announces Availability Of Concordia, A New Cell-Free DNA Purification Upgrade For Its LiquidBiopsy Whole Blood Enrichment Platform

  2/10/2016

• Cynvenio And Atgen Open Recruitment For New Liquidbiopsy Clinical Research Study In Triple Negative Breast Cancer

  12/28/2015

• Cynvenio Announces New PD-L1 Test For Tumor Cells In Blood

  10/1/2015

• Cynvenio And ATGen Announce Strategic Partnership To Bring NK Vue Natural Killer Cell Test To US Market

  9/28/2015

• Cynvenio Receives Accreditation From College of American Pathologists

  9/8/2015

• Cynvenio Appoints Leading Oncologist And Seasoned Medical Executive Paul Y. Song, M.D., As Chief Medical Officer

  9/4/2015

• Week In Review: Livzon Leads $26 Million Funding Of Cynvenio

  6/22/2015

• SoCal's Cynvenio Reels In $25.5 Million

  6/18/2015

• Cynvenio’s CLIA Lab And Venture-Backed Cure Forward Partner To Empower Cancer Patients With Access To Genomic Information From Standard Whole Blood Draw

  6/18/2015

• SoCal's Cynvenio Locks In $25.5 Million

  6/5/2015

• Livzon To Form China JV With Cynvenio

  5/20/2015

• Cynvenio Biosystems, Inc. To Present New Clinical Data On Concordance Characteristics Of Circulating Cell-Free Nucleic Acids In Metastatic Cancer Mutations At Molecular Diagnostics Europe

  4/13/2015

• Thermo Fisher Scientific Signs Distribution Agreement With Cynvenio Biosystems, Inc. For LiquidBiopsy Platform

  1/13/2015

• Cynvenio Biosystems, Inc. Release: ClearID Breast Cancer Genomic Test Is Now Reimbursable Under Most Health Insurance Plans

  9/18/2014